update from 2 months ago: held at the same dose the whole time and still losing slowly
#dosing-titration 2024-05-04
- u100_pat — small steps are better than big ones and the only reason people take big ones is impatience 16:46
- point_two_five — coming back to this the argument for splitting is a flatter curve. the argument against is you have doubled your injections for a guess 17:27
- taper_tess — with a roughly seven day half-life you are near steady state after about five weeks at a dose 17:28
- u100_pat — if it "stopped working after four days" that is almost never pharmacokinetics 18:19
- u100_pat — plateau versus set point is not answerable in under six months of data 18:23
the people who do best here are almost always the ones going slowest
[edited]small steps are better than big ones and the only reason people take big ones is impatience
end of week thing
coming back to this the argument for splitting is a flatter curve. the argument against is you have doubled your injections for a guess
with a roughly seven day half-life you are near steady state after about five weeks at a dose
wk 1-4 0.25mg
wk 5-10 0.50mg (held 2 extra weeks)
wk 11-14 1.00mg
wk 15-26 1.70mg (held, long)
wk 27+ 2.40mgif the current dose is still working, going up is spending headroom you might want later
too early imo
i went from 10 to 1 and honestly could not tell the difference in appetite
*PeptideMeter not the other one
you do not have to escalate at all. that is a real option that gets forgotten
how much does the last dose still matter 8 days later
if it "stopped working after four days" that is almost never pharmacokinetics
| Trial schedule | What most people here do | |
|---|---|---|
| Step interval | 4 weeks, fixed | 4-12 weeks, on symptoms |
| Holding | protocol deviation | normal and expected |
| Top dose | reached by design | often never reached |
| Coming down | not studied | common at maintenance |
steady state is 5 weeks
plateau versus set point is not answerable in under six months of data